Palot M, Visseaux H, Botmans C
Département d'Anesthésie-Réanimation, CHU de Reims.
Cah Anesthesiol. 1995;43(6):547-53.
The placental transfer of local anaesthetics (LA) depends on maternal, placental and fetal factors. The assessment of effects of LA and epidural anaesthesia (EA) on the fetus is based on the monitoring of fetal heart rate (FHR) and the measurement of the fetal pH. Apgar score and neurobehavioral tests allow an evaluation of the neonatal effects of the drugs used. Direct effects of LA: a diminution of variability of FHR was observed shortly after the beginning of an EA using lidocaine but there was no modification of FHR after EA using bupivacaine or lidocaine with epinephrine. Fetal neurological toxicity is rare and there are very few alterations of neurobehavioral scores after EA. Indirect effects on uteroplacental blood flow (UBF): in high concentration, LA can induce vasoconstriction of uterine arteries but maternal arterial hypotension that impedes directly uteroplacental blood flow is the main effect. Prevention of aortocaval compression is essential because it allows better Apgar scores and arterial pH at birth. Use of colloids has not a better preventive efficacy than an equal volume of cristalloids while dextrans are formally contra-indicated because of serious fetal accidents. Large iv infusion of dextrose solutions are responsible for maternal and fetal hyperglycemia and hyperinsulinemia leading to neonatal hypoglycemia. The utilization of IM prophylactic ephedrine is not useful while the therapeutic administration of ephedrine to treat maternal arterial hypotension is efficient. Phenylephrine used in case of maternal arterial hypotension seems as efficient as is ephedrine. Epidural narcotics: the use of morphine by epidural route can induce neonatal respiratory depression and low neurobehavioral scores. The epidural administration of fentanyl does not alter the variability of the FHR and does not modify neither Apgar or neurobehavioral scores, nor respiratory adaptation of the newborn. Use of epidural alfentanil or sufentanil does not lead to low neurobehavioral scores unless very high doses are used. For elective caesarean section, newborns present a lower Apgar score at 1 min and necessitate respiratory assistance more frequently after general anaesthesia (GA) than after EA. Neurobehavioral scores are better after EA than after GA. For emergency caesarean section, the percentage of newborns with an Apgar score < 4 or necessitating a respiratory assistance is more important after GA than after EA. However, the perinatal mortality is not more important after GA than after EA.
局部麻醉药(LA)的胎盘转运取决于母体、胎盘和胎儿因素。评估LA和硬膜外麻醉(EA)对胎儿的影响基于对胎儿心率(FHR)的监测以及胎儿pH值的测量。阿氏评分和神经行为测试有助于评估所用药物对新生儿的影响。LA的直接影响:使用利多卡因进行EA后不久,观察到FHR变异性降低,但使用布比卡因或含肾上腺素的利多卡因进行EA后,FHR没有改变。胎儿神经毒性很少见,EA后神经行为评分的改变也很少。对子宫胎盘血流(UBF)的间接影响:高浓度时,LA可引起子宫动脉血管收缩,但直接阻碍子宫胎盘血流的母体动脉低血压是主要影响。预防主动脉腔静脉受压至关重要,因为这可使出生时阿氏评分和动脉pH值更好。使用胶体溶液的预防效果并不优于等量的晶体溶液,而右旋糖酐因严重的胎儿意外而被正式禁用。大量静脉输注葡萄糖溶液会导致母体和胎儿高血糖及高胰岛素血症,进而导致新生儿低血糖。预防性肌内注射麻黄碱无效,而治疗性使用麻黄碱治疗母体动脉低血压则有效。母体动脉低血压时使用去氧肾上腺素似乎与麻黄碱一样有效。硬膜外麻醉性镇痛药:硬膜外途径使用吗啡可导致新生儿呼吸抑制和神经行为评分降低。硬膜外给予芬太尼不会改变FHR的变异性,也不会改变阿氏评分或神经行为评分,也不会改变新生儿的呼吸适应性。使用硬膜外阿芬太尼或舒芬太尼除非使用非常高的剂量,否则不会导致神经行为评分降低。对于择期剖宫产,与EA后相比,全身麻醉(GA)后新生儿1分钟时阿氏评分较低,且更频繁地需要呼吸支持。EA后神经行为评分优于GA后。对于紧急剖宫产,GA后阿氏评分<4或需要呼吸支持的新生儿百分比高于EA后。然而,GA后的围产期死亡率并不高于EA后。